Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. Appay R, et al. Among authors: ducray f. Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124. Neuro Oncol. 2019. PMID: 31832685 Free PMC article.
[Management of malignant gliomas diagnosed during pregnancy].
Ducray F, Colin P, Cartalat-Carel S, Pelissou-Guyotat I, Mahla K, Audra P, Gaucherand P, Honnorat J, Trouillas P. Ducray F, et al. Rev Neurol (Paris). 2006 Mar;162(3):322-9. doi: 10.1016/s0035-3787(06)75018-4. Rev Neurol (Paris). 2006. PMID: 16585887 French.
No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
El Hallani S, Marie Y, Idbaih A, Rodero M, Boisselier B, Laigle-Donadey F, Ducray F, Delattre JY, Sanson M. El Hallani S, et al. Among authors: ducray f. J Neurooncol. 2007 Dec;85(3):241-4. doi: 10.1007/s11060-007-9416-1. Epub 2007 Jun 14. J Neurooncol. 2007. PMID: 17568997
TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: ducray f. Cancer Genet Cytogenet. 2007 Sep;177(2):103-7. doi: 10.1016/j.cancergencyto.2007.06.010. Cancer Genet Cytogenet. 2007. PMID: 17854663
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Kaloshi G, Everhard S, Laigle-Donadey F, Marie Y, Navarro S, Mokhtari K, Idbaih A, Ducray F, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M. Kaloshi G, et al. Among authors: ducray f. Neurology. 2008 Feb 19;70(8):590-5. doi: 10.1212/01.wnl.0000299896.65604.ae. Neurology. 2008. PMID: 18285534 Clinical Trial.
[Systemic metastases of malignant gliomas].
Fourtassi M, Psimaras D, Ducray F, Sanson M. Fourtassi M, et al. Among authors: ducray f. Bull Cancer. 2008 May;95(5):522-5. doi: 10.1684/bdc.2008.0627. Bull Cancer. 2008. PMID: 18541516 Free article. French.
Genomic changes in progression of low-grade gliomas.
Idbaih A, Carvalho Silva R, Crinière E, Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: ducray f. J Neurooncol. 2008 Nov;90(2):133-40. doi: 10.1007/s11060-008-9644-z. Epub 2008 Jul 11. J Neurooncol. 2008. PMID: 18618226
216 results